CANOPY Y IMMUNO-THERAPEUTICS

Welcome to the Brand page for “CANOPY Y IMMUNO-THERAPEUTICS”, which is offered here for The mark consists of the stylized wording canopy with the letter y forming a design of a tree and the wordings immuno-therapeutics below.;pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases and disorders; pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases, by eliminating specific lymphocytes' lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes' lineages and attenuate or block antibody creation and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; pharmaceutical recombinant proteins and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies igg, ige or iga and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials with potential immunomodulation activity to treat under and over responsiveness of the immune system for the treatment of autoimmune diseases and disorders;color is not claimed as a feature of the mark.;immuno-therapeutics;.

Its status is currently believed to be active. Its class is unavailable. “CANOPY Y IMMUNO-THERAPEUTICS” is believed to be currently owned by “CANOPY IMMUNO-THERAPEUTICS LTD.”

Owner:
CANOPY IMMUNO-THERAPEUTICS LTD.
Owner Details
Description:
The mark consists of the stylized wording CANOPY with the letter Y forming a design of a tree and the wordings IMMUNO-THERAPEUTICS below.;Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials for the treatment of autoimmune diseases, by eliminating specific lymphocytes' lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes' lineages and attenuate or block antibody creation and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant proteins and substances not related to pharmaceuticals and clinical trials that modulate the immune system by recombinant proteins that contain a targeting moiety and an effect or moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen-specific immune response in autoimmune diseases for the treatment of autoimmune diseases and disorders; Pharmaceutical recombinant protein preparations and substances not related to pharmaceuticals and clinical trials with potential immunomodulation activity to treat under and over responsiveness of the immune system for the treatment of autoimmune diseases and disorders;Color is not claimed as a feature of the mark.;IMMUNO-THERAPEUTICS;
Categories: